Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated by Anal

StockNews.com began coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Aptevo Therapeutics Stock Performance Shares of APVO opened at $0.14 on Thursday. The firm’s fifty day simple moving average is $0.16 and its 200-day simple […]

Related Keywords

United States , Cantor Fitzgerald , Aptevo Therapeutics Company Profile , Renaissance Technologies , Sabby Management , Aptevo Therapeutics Inc , Citadel Advisors , Armistice Capital , Aptevo Therapeutics , Get Free Report , Therapeutics Inc , Aptevo Therapeutics Daily , Nasdaq Apvo , Apvo , Medical , Initiated Coverage , Stocknews Com ,